Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Revenue: 2021-2024

Historic Revenue for Krystal Biotech (KRYS) over the last 3 years, with Dec 2024 value amounting to $290.5 million.

  • Krystal Biotech's Revenue rose 16.65% to $97.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $373.2 million, marking a year-over-year increase of 54.46%. This contributed to the annual value of $290.5 million for FY2024, which is 473.01% up from last year.
  • According to the latest figures from FY2024, Krystal Biotech's Revenue is $290.5 million, which was up 473.01% from $50.7 million recorded in FY2023.
  • In the past 5 years, Krystal Biotech's Revenue registered a high of $290.5 million during FY2024, and its lowest value of -$1.5 million during FY2021.
  • For the 2-year period, Krystal Biotech's Revenue averaged around $170.6 million, with its median value being $170.6 million (2023).
  • Data for Krystal Biotech's Revenue shows a peak YoY soared of 473.01% (in 2024) over the last 5 years.
  • Krystal Biotech's Revenue (Yearly) stood at -$1.5 million in 2021, then reached $50.7 million in 2023, then spiked by 473.01% to $290.5 million in 2024.